期刊文献+

大肠癌转移相关分子标签的筛选 被引量:5

Screen Molecular Signatures Related to Colorectal Cancer Metastasis
原文传递
导出
摘要 目的:筛选与转移相关的大肠癌分子标签。方法:本文通过对大肠癌表达谱数据进行分析,按照表达谱中大肠癌转移情况,组织学分化程度以及患者生存时间进行显著性分析,将与大肠癌转移相关的具有显著性意义的基因群进行聚类,通过主成分分析以及自组织映射的方法计算出差异表达基因中,起着主体分类作用的基因群。结果:筛选出与肿瘤组织分化程度以及患者生存时间相关的差异表达基因,进行功能富集,并筛选出了一批与大肠癌转移密切相关的重要基因,这些基因对大肠癌早期诊断,及时治疗,预后评估有着重要意义。结论:细胞代谢,趋化因子信号通路和细胞因子受体等分子事件与大肠癌分化程度密切相关,是否发生转移与大肠癌的预后生存期密切相关。 Objective: o screen the molecular signature that related to the colorectal cancer metastasis. Methods: In this study, gene expression data of colorectal cancer were analyzed. Significant analysis were based on the gene expression data of colorectal cancer metastasis, histological differentiating degree and patients' survival time. The significant meaning genes that related to the colorectal cancer metastasis were clustered. The subject classification genes in differently expressed genes were calculated by the way of principal component analysis and sell-organizing mapping calculate. Results: Differently expressed genes that related to differentiation degree of tumor tissue and patients' survival time were selected, then its function was enriched. A collection of genes closely related to colorectal cancer metastasis was selected. These genes were great significance tbr the early diagnosis, prompt treatment and prognostic appraisal of colorectal cancer. Conclusion: Cell metabolism, signaling pathway ofchemokine, cytokine receptor and other molecular event are closely related to histological differentiating degree ofcolorectal cancer. Metastasis or not is closely related to patients' survival time.
出处 《现代生物医学进展》 CAS 2012年第27期5225-5229,共5页 Progress in Modern Biomedicine
基金 国家自然科学基金资助项目(30670967)
关键词 大肠癌 转移 分子标签 Colorectal cancer Metastasis Molecular signature
  • 相关文献

参考文献18

  • 1Yamauchi H, Togashi K, Kawamttra Y J, et al. Pathological predictors for lymph node metastasis in T1 colorectal cancer [J]. Surg Today,20 08,38(10):905-910.
  • 2Tsai M H, Wu C C, Peng P H, et al. Identification of secretory gelsolin as a plasma biomarker associated with distant organ metastasis of colorectal cancer[J]. J Mol Med (Berl),2012,90(2): 187-200.
  • 3Tsutsumi S, Watanabe R, Tabe Y, et al. Extranodal metastasis predicts poor survival in advanced colorectal cancer[J]. Hepatogastroenterolo- gy,2012,59(114):372-374.
  • 4Makela J T, Kiviniemi H. Surgical treatment of colorectal cancer in p- atients aged over 80 years [J]. Int J Colorectal Dis,2012,27(8):1055-1 060.
  • 5Chirica M, Leconte M, Oberlin O, et al. Surgical treatment of liver me- tastasis in patients with colorectal cancer [J]. Presse Med,2012,41(1): 58-67.
  • 6Barbulescu M, Alecu L, Boeti P, et al. Port-site metastasis after laparoscopic surgery for colorectal cancer--still a real concern? Case report and review of the literature[J]. Chirurgia (Bucur),2012,107(1): 103-107.
  • 7Lee J S, Leem S H, Lee S Y, et al. Expression signature of E2F1 and its associated genes predict superficial to invasive progression ofblad- der tumors[J]. J Clin Oncol,2010,28(16):2660-2667.
  • 8Croner R S, Fortsch T, Bruckl W M, et al. Molecular signature for lymphatic metastasis in colorectal carcinomas[J]. Ann Surg,2008,247 (5):803-810.
  • 9Joyce T, Cantarella D, Isella C, et al. A molecular signature for Epithelial to Mesenchymal transition in a human colon cancer cell system is revealed by large-scale microarray analysis [J]. Clin Exp Metastasis,2009,26(6):569-587.
  • 10Joyce T, Oikonomou E, Kosmidou V, et al. A molecular signature for oncogenic BRAF in human colon cancer cells is revealed by microa- rray analysis [J]. Curr Cancer Drug Targets,2012,Apr 19 [Epub ahead of print].

同被引文献42

  • 1李景南,李潇,钱家鸣,路新卿,杨红.K-ras基因突变通过调节E-cadherin/β-catenin/p120蛋白复合体形成和RhoA蛋白活性对结肠癌细胞株Caco-2转移的影响[J].中国医学科学院学报,2010,32(1):46-50. 被引量:10
  • 2Gialamas SP, Petridou ET, Tseleni-Balafouta S, et al. Serum adiponec- tin levels and tissue expression of adiponeetin receptors are associated with risk, stage, and grade of eolorectal cancer [J]. Metabolism, 2011, 60(11):1530-1538.
  • 3Nielsen HJ, Christensen IJ, Brunner N. A novel prognostic index in colorectal cancer defined by serum carcinoembryonic antigen and pla- sma tissue inhibitor ofmetalloproteinases-1 [J]. ScandJ Gastroentero, 2010, 45(2):200-207.
  • 4Lumachi F, Orlando R, Marino F, et al. Expression of p53 and Ki-67 as prognostic factors for survival of men with colorectal cancer[J]. An- ticancer Res, 2012, 32(9):3965-3967.
  • 5Holdenricder S, Stieber P, Liska V, et al. Cytokeratin serum biomarke- rs in patients with colorectat cancer [J]. Anticancer Res, 2012, 32(5): 1971-1976.
  • 6Mroczko B, Groblewska M, Okulczyk B, et al. The diagnostic value of matrix metalloproteinase 9 (MMP-9) and tissue inhibitor of matrix me- talloproteinases 1 (TIMP- 1) determination in the sera of colorectal ade- noma and cancer patients[J]. Int J Colorectal Dis, 2010, 25(10):1177- 1184.
  • 7Dragutinovi W, Radonji NV, Petronijevi ND, et al. Matrix metallop- roteinase-2 (MMP-2) and -9 (MMP-9) in preoperative serum as indep- endent prognostic markers in patients with colorectal cancer [J]. Mol Cell Biochem, 2011,355(1-2):173-178.
  • 8Toiyama Y,Fujikawa H, Kawamura M, et al. Evaluation of CXCL10 as a novel serum marker for predicting liver metastasis and prognosis in colorectal cancer[J]. Int J Oncol, 2012, 40(2):560-566.
  • 9Safont M J, Gil M, Sirera R, et al. The prognostic value of hTERT expression levels in advanced-stage colorectal cancer patients:a com- parison between tissue and serum expression [J]. Clin Transl Oncol, 2011, 13(6):396-400.
  • 10Hamelin C, Cornut E, Poirier F, et al. Identification and verification of heat shock protein 60 as a potential serum marker for colorectal cancer[J]. FEBS J, 2011,278(24):4845-4859.

引证文献5

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部